Search results
Immutep Announces Positive Preliminary Topline Results from TACTI-003 Cohort B
Morningstar· 6 days agoMedia Release Data from efti in combination with KEYTRUDA® in first line head and neck squamous cell carcinoma patients who do not express ...
Your expert guide to melanomas and how to spot them
The Telegraph via Yahoo News· 5 days agoIf you have noticed a lingering spot somewhere on your skin, it would be wise not to dismiss it, especially if there’s something unusual about its...
Why Australian Cancer Biotech Firm Immutep Stock Is Soaring On Wednesday?
Benzinga via Yahoo Finance· 6 days agoThe investigational immuno-oncology combination demonstrates an overall response rate (ORR) of 26.9%...
H.C. Wainwright Cuts HOOKIPA Pharma Shares target on Narrower HB-200 Target Population By...
Investing.com· 5 days agoThe adjustment followed HOOKIPA Pharma's announcement regarding the trial design of a Phase 2/3...
Junshi Biosciences Announces NDA Acceptance in Hong Kong for Toripalimab
Morningstar· 6 days agoThe NDA is supported by results from JUPITER-02, a randomized, double-blind, placebo-controlled, multinational...
Analysts Expect Moderna's First-Quarter Sales To Plummet 95% — Is Moderna Stock A Sell?
Investor's Business Daily· 6 days agoOverall, 27.3% responded to the treatment. A total of 63.6% of patients had their disease under...
Immutep Shares Rise 12% After Positive Data From Eftilagimod Trial
Market Watch· 6 days agoImmutep Limited shares were up 12% at $2.82 after the company said it saw positive preliminary topline results from its Phase IIb trial evaluating eftilagimod alpha, or efti, in combination ...
... (DART) Opposes Move to Cancel Medicare Coverage for Nonsurgical Treatment of Nonmelanoma Skin...
FOX 23 News Albany· 1 day ago"The local coverage determination, or LCD, if finalized in its current form, would cause a significant, adverse impact on patient choice and access to care for the treatment
Stereotactic Radiosurgery to Treat 15-Plus Brain Metastases?
Medscape· 19 hours agoA large study supports the use of stereotactic radiosurgery in patients with 15 or more brain...
Cancer diagnoses expected to increase by 77% by 2050
Journal-News, Hamilton, Ohio via Yahoo News· 9 hours agoApr. 30—Cancer diagnoses are expected to increase 77% worldwide by 2050 and new trends in the occurrence of human papillomavirus among cancer patients underscores the importance of the HPV vaccine ...
